Ghafoori Shahnaz, Keshtkar Abbasali, Khashayar Patricia, Ebrahimi Mehdi, Ramezani Majid, Mohammadi Zahra, Saeidifard Farzane, Nemati Nasrin, Khoshbin Maryam, Azizian Solmaz, Zare Fatemeh, Shirazi Sara, Larijani Bagher
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2014 Oct 22;13(1):93. doi: 10.1186/s40200-014-0093-2. eCollection 2014.
The present study is designed to assess the incidence rate of osteoporotic fracture and its risk factors, particularly those used to predict the 10-year risk of osteoporotic fracture in FRAX based on the data gathered through a follow up cohort initiated in 2000.
The present retrospective cohort was conducted on men and women from 40 to 90 years of age enrolled in the IROSTEOPs study. A phone survey was conducted during 2013 and beginning of 2014 to assess the fractures (traumatic/osteoporotic) occurring at the time of inclusion until the date of the telephone survey, its type and mechanism, and the patient's age at the time of accident. Survival analysis using Kaplan-Meier product-limit method was performed with the time of fracture as the study outcome.
Final study population consisted of 1233 individuals, translated in to 9133 person years. The incidence rate of osteoporotic fracture was reported to be 359.1 cases in every 10,000 person years. The 10-year Kaplan-Meier estimate of any kind of major osteoporotic fractures for all the subcohort population was 10.75%. Osteoporosis (HR = 0.75), Discordance between femoral neck and spine (HR = 1.45), Diabetes (HR = 1.81), IBD (HR = 1.84), immobility more than 90 days (HR = 2.19), and personal history of fracture (HR = 7.75) had a considerable effect on the 10-year risk of major osteoporotic fractures.
Adding new clinical risk factors to FRAX® may help improve fracture prediction in the Iranian population.
本研究旨在基于2000年启动的随访队列收集的数据,评估骨质疏松性骨折的发病率及其危险因素,特别是那些用于预测FRAX中骨质疏松性骨折10年风险的因素。
本回顾性队列研究针对纳入IROSTEOPs研究的40至90岁男性和女性进行。2013年至2014年初进行了电话调查,以评估纳入研究时直至电话调查日期发生的骨折(创伤性/骨质疏松性)、骨折类型和机制以及事故发生时患者的年龄。以骨折时间为研究结局,采用Kaplan-Meier乘积限界法进行生存分析。
最终研究人群包括1233人,总计9133人年。据报告,骨质疏松性骨折的发病率为每10000人年359.1例。所有亚组人群任何类型主要骨质疏松性骨折的10年Kaplan-Meier估计值为10.75%。骨质疏松(HR = 0.75)、股骨颈与脊柱不一致(HR = 1.45)、糖尿病(HR = 1.81)、炎症性肠病(HR = 1.84)、活动受限超过90天(HR = 2.19)以及骨折个人史(HR = 7.75)对主要骨质疏松性骨折的10年风险有相当大的影响。
在FRAX®中添加新的临床危险因素可能有助于改善伊朗人群的骨折预测。